TNFA

TNFA

USD

TNF Pharmaceuticals Inc. Common Stock

$5.200-0.430 (-7.638%)

Echtzeitkurs

Technologie
Computerhardware
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$5.630

Hoch

$8.900

Tief

$4.200

Volumen

0.52M

Unternehmensfundamentaldaten

Marktkapitalisierung

9.6M

Branche

Computerhardware

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.82M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $3.24Aktuell $5.200Hoch $195

Ähnliche Nachrichten

BusinessWire

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"

Licensed technology positions Company at forefront of new quantum-class computing paradigm

Mehr anzeigen
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
BusinessWire

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing

New trading symbol QCLS effective Thursday, September 25, 2025 Licensed technology positions Company at forefront of new quantum-class computing paradigm TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("Q/C" or the

Mehr anzeigen
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing
BusinessWire

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals Inc. (NASDAQ:TNFA), ("TNF" or the "Company") today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company has regained compliance

Mehr anzeigen
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
BusinessWire

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Management to present on Wednesday, September 10, 2025, at 8:00 a.m. ET TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company") today announced its participation in the H.C. Wainwright & Co. 27th Annual

Mehr anzeigen
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference